Prioritize Drug Targets from Compound Structures

Purpose

Starting from one or more small-molecule structures, generate evidence-backed target hypotheses, assess compound quality and chemical-series structure, retrieve annotated neighbors and activity data, validate target/disease context, identify patent review questions, and propose orthogonal experiments and medicinal-chemistry directions.

This workflow supports hypothesis generation and prioritization. It does not prove target engagement, efficacy, safety, patent novelty, freedom to operate, or clinical value.

Use this skill when

• a user has a compound library and wants reverse target identification;
• a user asks what target a SMILES may modulate;
• a chemistry team wants series-level target hypotheses and SAR;
• target hypotheses need biological, pipeline, patent, and experimental validation;
• an evidence-backed shortlist is needed for biochemical, biophysical, cellular, genetic, or omics follow-up.

Do not use it for: